Teachers Retirement System of The State of Kentucky purchased a new position in Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 24,800 shares of the company’s stock, valued at approximately $934,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in GRDN. Ameritas Investment Partners Inc. boosted its holdings in Guardian Pharmacy Services by 26.5% in the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after acquiring an additional 345 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Guardian Pharmacy Services in the 2nd quarter worth about $43,000. State of Wyoming bought a new position in Guardian Pharmacy Services in the 2nd quarter worth about $58,000. Strs Ohio bought a new position in Guardian Pharmacy Services in the 4th quarter worth about $75,000. Finally, Clearstead Advisors LLC grew its position in Guardian Pharmacy Services by 196.3% during the 4th quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock valued at $79,000 after purchasing an additional 1,741 shares during the last quarter.
Guardian Pharmacy Services Trading Up 0.6%
Shares of GRDN stock opened at $40.19 on Friday. Guardian Pharmacy Services, Inc. has a 12-month low of $19.30 and a 12-month high of $44.00. The stock has a market capitalization of $2.00 billion, a P/E ratio of 48.42, a P/E/G ratio of 2.62 and a beta of 0.05. The firm’s 50 day moving average is $39.85 and its 200 day moving average is $35.98.
Wall Street Analyst Weigh In
Several brokerages have issued reports on GRDN. Wall Street Zen cut shares of Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. Zacks Research cut shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a report on Monday, May 11th. Jefferies Financial Group began coverage on shares of Guardian Pharmacy Services in a research report on Monday, March 30th. They set a “buy” rating and a $44.00 price target for the company. Bank of America upped their price objective on Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a “buy” rating in a research report on Wednesday, June 17th. Finally, Weiss Ratings lowered Guardian Pharmacy Services from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, May 11th. Seven research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, Guardian Pharmacy Services currently has an average rating of “Moderate Buy” and a consensus price target of $42.83.
View Our Latest Report on Guardian Pharmacy Services
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.
See Also
- Five stocks we like better than Guardian Pharmacy Services
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
